Dronabinol

Dronabinol

SCHEMBL1697394

CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CNR1

The experimentally established mechanism targets of Dronabinol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 known ✓ P21554 10/20 0.71
CNR2 P34972 16/20 0.71
ABHD12 Q8N2K0 3/20 0.71
ABHD6 Q9BV23 3/20 0.71
FAAH O00519 2/20 0.71
TRPM8 Q7Z2W7 2/20 0.71
GPR55 Q9Y2T6 2/20 0.71
NR1I2 O75469 1/20 0.71
LDHA P00338 1/20 0.71
GLRA1 P23415 1/20 0.71
GPR183 P32249 1/20 0.71
DRD3 P35462 1/20 0.71
ENPP2 Q13822 1/20 0.71
GPR18 Q14330 1/20 0.71
TRPA1 O75762 1/20 0.62
HTR1A P08908 1/20 0.62
TRPV1 Q8NER1 1/20 0.62
TRPV3 Q8NET8 1/20 0.62
TRPV6 Q9H1D0 1/20 0.62
TRPV4 Q9HBA0 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dronabinol SCHEMBL29410178 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL29422026 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL11375978 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL1227386 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL13214137 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL24702729 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL3686519 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL13394311 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL22705549 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL4609 0.84 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210008139-A1 CANNABIS COMPOSITIONS AND METHODS 3277991 Nova Scotia Limited (CA) 2021-01-14 US disclosed
US-10765713-B2 Cannabis compositions and methods 3277991 Nova Scotia Limited (CA) 2020-09-08 US disclosed
US-20190321425-A1 CANNABIS COMPOSITIONS AND METHODS KANNABLISS TECHNOLOGIES INC. (CA) 2019-10-24 US disclosed
EP-3478308-A1 CANNABIS COMPOSITIONS AND METHODS 3277991 Nova Scotia Limited (CA) 2019-05-08 EP disclosed
WO-2018006165-A1 CANNABIS COMPOSITIONS AND METHODS 3277991 NOVA SCOTIA LIMITED D/B/A TRURO HERBAL CO. (CA) 2018-01-11 WO disclosed
US-20130149380-A1 USE OF DIATOMACEOUS EARTH IN THE PHARMACEUTICAL INDUSTRY ONP HOLDINGS SE (CY) 2013-06-13 US disclosed
EP-2575779-A2 USE OF DIATOMACEOUS EARTH IN THE PHARMACEUTICAL INDUSTRY Egis Gyógyszergyár Nyilvánosan Müködö Részvénytársaság (HU) 2013-04-10 EP disclosed
CN-103025316-A Use of diatomaceous earth in the medical industry EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZVENYTARSASAG 2013-04-03 CN disclosed
WO-2011148209-A2 NEW USE OF DIATOMACEOUS EARTH IN THE PHARMACEUTICAL INDUSTRY EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) 2011-12-01 WO disclosed
US-20110236475-A1 GRANULAR PHARMACEUTICAL COMPOSITIONS DR. REDDY'S LABORATORIES LTD. (IN) 2011-09-29 US disclosed
US-20090252787-A1 GRANULAR PHARMACEUTICAL COMPOSITIONS DR. REDDY'S LABORATORIES LTD. (IN) 2009-10-08 US disclosed
EP-2068837-A2 GRANULAR PHARMACEUTICAL COMPOSITIONS Dr. Reddy's Laboratories Ltd. (IN) 2009-06-17 EP disclosed
WO-2009006299-A2 MULTI-PARTICULATE SYSTEMS DR. REDDY'S LABORATORIES LTD. (IN) 2009-01-08 WO disclosed
WO-2008014175-A2 GRANULAR PHARMACEUTICAL COMPOSITIONS DR. REDDY'S LABORATORIES LTD. (IN) 2008-01-31 WO disclosed
WO-2006117803-A2 TRANSMUCOSAL DRUG DELIVERY SYSTEMS DEVARAJAN, PADMA, VENKITACHALAM (IN) 2006-11-09 WO disclosed